A Randomized Controlled Phase 2 Trial of ARQ 197 in Patients With Unresectable Hepatocellular Carcinoma (HCC) Who Have Failed One Prior Systemic Therapy

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 13 Dec 2023

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

11 Oct 2016 Results of post-hoc exploratory analysis (n=98) presented at the 41st European Society for Medical Oncology Congress (2016).
25 Jan 2016 Results presented at the 2016 Gastrointestinal Cancers Symposium, as per ArQule media release.
25 Jan 2016 According to ArQule media release, results were published in The Lancet Oncology medical journal in November 2012.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com